{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,27]],"date-time":"2026-05-27T20:00:16Z","timestamp":1779912016682,"version":"3.53.1"},"reference-count":68,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2023,1,26]],"date-time":"2023-01-26T00:00:00Z","timestamp":1674691200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,1,26]],"date-time":"2023-01-26T00:00:00Z","timestamp":1674691200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pharm Res"],"published-print":{"date-parts":[[2023,3]]},"DOI":"10.1007\/s11095-022-03467-9","type":"journal-article","created":{"date-parts":[[2023,1,26]],"date-time":"2023-01-26T21:02:53Z","timestamp":1674766973000},"page":"675-687","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Brain Targeted Curcumin Loaded Turmeric Oil Microemulsion Protects Against Trimethyltin Induced Neurodegeneration in Adult Zebrafish: A Pharmacokinetic and Pharmacodynamic Insight"],"prefix":"10.1007","volume":"40","author":[{"given":"Suraj","family":"More","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Atmaram","family":"Pawar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,1,26]]},"reference":[{"key":"3467_CR1","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1016\/S1474-4422(18)30499-X","volume":"18","author":"VL Feigin","year":"2019","unstructured":"Feigin VL, Nichols E, Alam T, Bannick MS, Beghi E, Blake N, et al. Global, regional, and national burden of neurological disorders, 1990\u20132016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet Neurol. 2019;18:459\u201380.","journal-title":"Lancet Neurol"},{"key":"3467_CR2","doi-asserted-by":"crossref","unstructured":"Darvesh AS, Carroll RT, Bishayee A, Novotny NA, Geldenhuys WJ, Van der Schyf CJ. Curcumin and neurodegenerative diseases: a perspective. Expert Opin Investig Drugs [Internet]. 2012;21:1123\u201340. Available from: http:\/\/www.tandfonline.com\/doi\/full\/10.1517\/13543784.2012.693479","DOI":"10.1517\/13543784.2012.693479"},{"key":"3467_CR3","unstructured":"Raghavan A, Shah ZA. Neurodegenerative disease. Diet, Exerc Chronic Dis Biol Basis Prev. 2014;339\u201390."},{"key":"3467_CR4","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1093\/ecam\/nel071","volume":"3","author":"S-N Dos","year":"2006","unstructured":"Dos S-N, De Vilhena Toledo MA, Medeiros-Souza P, De Souza GA. The use of herbal medicine in Alzheimer\u2019s disease - A systematic review. Evidence-based Complement Altern Med. 2006;3:441\u20135.","journal-title":"Evidence-based Complement Altern Med"},{"key":"3467_CR5","unstructured":"Bharat B. A, Chitra S, Nikita M, Haruyo I. Curcumin: The Indian solid gold. Adv Exp Med Biol [Internet]. 2007;595:1\u201375. Available from: http:\/\/www.embase.com\/search\/results?subaction=viewrecord&from=export&id=L354122020"},{"key":"3467_CR6","doi-asserted-by":"publisher","unstructured":"Maheshwari RK, Singh AK, Gaddipati J, Srimal RC. Multiple biological activities of curcumin: A short review. Life Sci [Internet]. Elsevier B.V.; 2006;78:2081\u20137. Available from: https:\/\/doi.org\/10.1016\/j.lfs.2005.12.007","DOI":"10.1016\/j.lfs.2005.12.007"},{"key":"3467_CR7","doi-asserted-by":"publisher","first-page":"91","DOI":"10.2174\/138161212798918995","volume":"18","author":"RB Mythri","year":"2012","unstructured":"Mythri RB, Srinivas Bharath MM. Curcumin: a potential neuroprotective agent in parkinson\u2019s disease. Curr Pharm Des. 2012;18:91\u20139.","journal-title":"Curr Pharm Des"},{"key":"3467_CR8","doi-asserted-by":"publisher","first-page":"1615","DOI":"10.3892\/etm.2015.2749","volume":"10","author":"D Perrone","year":"2015","unstructured":"Perrone D, Ardito F, Giannatempo G, Dioguardi M, Troiano G, Lo Russo L, et al. Biological and therapeutic activities, and anticancer properties of curcumin (Review). Exp Ther Med. 2015;10:1615\u201323.","journal-title":"Exp Ther Med"},{"key":"3467_CR9","doi-asserted-by":"crossref","unstructured":"Shehzad A, Islam SU, Lee YS. Curcumin and Inflammatory Brain Diseases. Curcumin Neurol Psychiatr Disord. 2019. p. 437\u201358.","DOI":"10.1016\/B978-0-12-815461-8.00024-4"},{"key":"3467_CR10","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1111\/j.1755-5949.2010.00147.x","volume":"16","author":"T Hamaguchi","year":"2010","unstructured":"Hamaguchi T, Ono K, Yamada M. Curcumin and Alzheimer\u2019s disease. CNS Neurosci Ther. 2010;16:285\u201397.","journal-title":"CNS Neurosci Ther"},{"key":"3467_CR11","unstructured":"Liu W, Zhai Y, Heng X, Che FY, Chen W, Sun D, et al. Oral bioavailability of curcumin: problems and advancements. J Drug Target [Internet]. 2016;2330:1\u20139. Available from: http:\/\/www.scopus.com\/inward\/record.url?eid=2-s2.0-84961217782&partnerID=tZOtx3y1"},{"key":"3467_CR12","doi-asserted-by":"publisher","first-page":"2","DOI":"10.4143\/crt.2014.46.1.2","volume":"46","author":"S Prasad","year":"2014","unstructured":"Prasad S, Tyagi AK, Aggarwal BB. Recent developments in delivery, bioavailability, absorption and metabolism of curcumin: The golden pigment from golden spice. Cancer Res Treat. 2014;46:2\u201318.","journal-title":"Cancer Res Treat"},{"key":"3467_CR13","doi-asserted-by":"crossref","unstructured":"Hucklenbroich J, Klein R, Neumaier B, Graf R, Fink G, Schroeter M, et al. Aromatic-turmerone induces neural stem cell proliferation in vitro and in vivo. Stem Cell Res Ther [Internet]. 2014;5:100. Available from: http:\/\/stemcellres.com\/content\/5\/4\/100","DOI":"10.1186\/scrt500"},{"key":"3467_CR14","doi-asserted-by":"crossref","unstructured":"Lee Y. Activation of apoptotic protein in U937 cells by a component of turmeric oil. BMB Rep [Internet]. 2009;42:96\u2013100. Available from: http:\/\/koreascience.or.kr\/journal\/view.jsp?kj=E1MBB7&py=2009&vnc=v42n2&sp=96","DOI":"10.5483\/BMBRep.2009.42.2.096"},{"key":"3467_CR15","unstructured":"Lee J. Induction of apoptosis by ar-turmerone on various cell lines. Int J Mol Med [Internet]. 2004;14:253\u20136. Available from: https:\/\/www.spandidos-publications.com\/10.3892\/ijmm.14.2.253"},{"key":"3467_CR16","doi-asserted-by":"crossref","unstructured":"Jankasem M, Wuthi-udomlert M, Gritsanapan W. Antidermatophytic Properties of Ar -Turmerone , Turmeric Oil , and Curcuma longa Preparations. 2013;2013.","DOI":"10.1155\/2013\/250597"},{"key":"3467_CR17","doi-asserted-by":"publisher","unstructured":"Park SY, Jin ML, Kim YH, Kim Y, Lee SJ. Anti-inflammatory effects of aromatic-turmerone through blocking of NF-\u03baB, JNK, and p38 MAPK signaling pathways in amyloid \u03b2-stimulated microglia. Int Immunopharmacol [Internet]. Elsevier B.V.; 2012;14:13\u201320. Available from: https:\/\/doi.org\/10.1016\/j.intimp.2012.06.003","DOI":"10.1016\/j.intimp.2012.06.003"},{"key":"3467_CR18","doi-asserted-by":"crossref","unstructured":"Park SY, Kim YH, Lee S-J. Aromatic-turmerone\u2019s anti-inflammatory effects in microglial cells are mediated by protein kinase A and heme oxygenase-1 signaling. Neurochem Int [Internet]. Elsevier Ltd; 2012;61:767\u201377. Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/22766494","DOI":"10.1016\/j.neuint.2012.06.020"},{"key":"3467_CR19","doi-asserted-by":"publisher","first-page":"3653","DOI":"10.1002\/jcb.24238","volume":"113","author":"SY Park","year":"2012","unstructured":"Park SY, Kim YH, Kim Y, Lee SJ. Aromatic-turmerone attenuates invasion and expression of MMP-9 and COX-2 through inhibition of NF-??B activation in TPA-induced breast cancer cells. J Cell Biochem. 2012;113:3653\u201362.","journal-title":"J Cell Biochem"},{"key":"3467_CR20","doi-asserted-by":"crossref","unstructured":"Yue GGL, Cheng S-W, Yu H, Xu Z, Lee JKM, Hon P-M, et al. The role of turmerones on curcumin transportation and p-glycoprotein activities in intestinal caco-2 cells. J Med Food [Internet]. 2012;15:242\u201352. Available from: http:\/\/www.liebertpub.com\/doi\/10.1089\/jmf.2011.1845","DOI":"10.1089\/jmf.2011.1845"},{"key":"3467_CR21","unstructured":"Benny A, Moni Abraham K, Mani Georgekutty P. Formulation of curcumin with enhanced bioavailability of curcumin and method of preparation and treatment thereof [Internet]. United States; 2019. Available from: https:\/\/patents.google.com\/patent\/US20200108148A1\/en"},{"key":"3467_CR22","doi-asserted-by":"publisher","unstructured":"More SK, Pawar AP. Preparation, optimization and preliminary pharmacokinetic study of curcumin encapsulated turmeric oil microemulsion in zebra fish. Eur J Pharm Sci [Internet]. Elsevier; 2020;155:105539. Available from: https:\/\/doi.org\/10.1016\/j.ejps.2020.105539","DOI":"10.1016\/j.ejps.2020.105539"},{"key":"3467_CR23","doi-asserted-by":"crossref","unstructured":"Zhang C, Willett C, Fremgen T. Zebrafish: an animal model for toxicological studies. Curr Protoc Toxicol [Internet]. 2003;1.7.1\u20131.7.18. Available from: http:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/0471140856.tx0107s17\/full","DOI":"10.1002\/0471140856.tx0107s17"},{"key":"3467_CR24","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1016\/S0959-437X(00)00074-5","volume":"10","author":"K Dooley","year":"2000","unstructured":"Dooley K, Zon LI. Zebrafish: a model system for the study of human disease. Curr Opin Genet Dev. 2000;10:252\u20136.","journal-title":"Curr Opin Genet Dev"},{"key":"3467_CR25","doi-asserted-by":"publisher","unstructured":"Pickart MA, Klee EW. Zebrafish approaches enhance the translational research tackle box. Transl Res [Internet]. Mosby, Inc; 2014;163:65\u201378. Available from: https:\/\/doi.org\/10.1016\/j.trsl.2013.10.007","DOI":"10.1016\/j.trsl.2013.10.007"},{"key":"3467_CR26","doi-asserted-by":"crossref","unstructured":"Chakraborty C, Hsu CH, Wen ZH, Lin CS, Agoramoorthy G. Zebrafish: a complete animal model for in vivo drug discovery and development. Curr Drug Metab [Internet]. 2009;10:116\u201324. Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/19275547","DOI":"10.2174\/138920009787522197"},{"key":"3467_CR27","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1016\/j.bbadis.2010.09.012","volume":"1812","author":"M Newman","year":"2011","unstructured":"Newman M, Verdile G, Martins RN, Lardelli M. Zebrafish as a tool in Alzheimer\u2019s disease research. Biochim Biophys Acta - Mol Basis Dis. 2011;1812:346\u201352.","journal-title":"Biochim Biophys Acta - Mol Basis Dis"},{"key":"3467_CR28","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fgene.2014.00189","volume":"5","author":"M Newman","year":"2014","unstructured":"Newman M, Ebrahimie E, Lardelli M. Using the zebrafish model for Alzheimer\u2019s disease research. Front Genet. 2014;5:1\u201310.","journal-title":"Front Genet"},{"key":"3467_CR29","unstructured":"Surendra V, Raj Sharma U, Goli D. Behavioral studies of different drugs using zebrafish as a model. Int J Pharmagenes [Internet]. 2011;2:75\u201382. Available from: http:\/\/serialsjournals.com\/serialjournalmanager\/pdf\/1331634585.pdf"},{"key":"3467_CR30","doi-asserted-by":"crossref","unstructured":"Kumar B, Tharumasivam SV, Boominathan V, Perumal E, Dhandapani P, Kaliyaperumal K, et al. A pilot study on nanotherapy of momordica charantia against trimethyltin chloride-induced neurotoxicity in danio rerio (Zebrafish). J Nanomater. 2021;2021.","DOI":"10.1155\/2021\/2180638"},{"key":"3467_CR31","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1016\/S0376-6357(02)00025-6","volume":"58","author":"FE Williams","year":"2002","unstructured":"Williams FE, White D, Messer WS. A simple spatial alternation task for assessing memory function in zebrafish. Behav Processes. 2002;58:125\u201332.","journal-title":"Behav Processes"},{"key":"3467_CR32","doi-asserted-by":"publisher","unstructured":"Koehler D, Shah ZA, Hensley K, Williams FE. Lanthionine ketimine-5-ethyl ester provides neuroprotection in a zebrafish model of okadaic acid-induced Alzheimer\u2019s disease. Neurochem Int [Internet]. Elsevier Ltd; 2018;115:61\u20138. Available from: https:\/\/doi.org\/10.1016\/j.neuint.2018.02.002","DOI":"10.1016\/j.neuint.2018.02.002"},{"key":"3467_CR33","unstructured":"Avdesh A, Chen M, Martin-iverson MT, Verdile G, Mondal A, Martins RN. Natural colour preference in the zebrafish (Danio rerio). Proc Meas Behav [Internet]. 2010;2010:155\u20137. Available from: http:\/\/measuringbehavior.org\/files\/ProceedingsPDF(website)\/Avdesh_FullPaper1.7.pdf"},{"key":"3467_CR34","doi-asserted-by":"publisher","first-page":"17","DOI":"10.36959\/418\/578","volume":"1","author":"S Dawn","year":"2017","unstructured":"Dawn S, Mohammad KA. An assessment of zebrafish natural color preference and its modification by stimuli. J Mood Disord Ther. 2017;1:17\u201323.","journal-title":"J Mood Disord Ther"},{"key":"3467_CR35","doi-asserted-by":"publisher","unstructured":"Anand SK, Sahu MR, Mondal AC. Induction of oxidative stress and apoptosis in the injured brain: potential relevance to brain regeneration in zebrafish. Mol Biol Rep [Internet]. Springer Netherlands; 2021;48:5099\u2013108. Available from: https:\/\/doi.org\/10.1007\/s11033-021-06506-7","DOI":"10.1007\/s11033-021-06506-7"},{"key":"3467_CR36","doi-asserted-by":"crossref","unstructured":"Buege JA, Aust SD. Biomembranes - part C: Biological oxidations. Methods Enzymol [Internet]. 1978;52:302\u201310. Available from: http:\/\/www.sciencedirect.com\/science\/article\/pii\/S0076687978520326","DOI":"10.1016\/S0076-6879(78)52032-6"},{"key":"3467_CR37","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1016\/0003-2697(71)90370-8","volume":"44","author":"C Beauchamp","year":"1971","unstructured":"Beauchamp C, Fridovich I. Superoxide dismutase: Improved assays and an assay applicable to acrylamide gels. Anal Biochem. 1971;44:276\u201387.","journal-title":"Anal Biochem"},{"key":"3467_CR38","doi-asserted-by":"publisher","unstructured":"Kharat S, Namdeo A, Mehta P. Development and validation of HPTLC method for simultaneous estimation of curcumin and galangin in polyherbal capsule dosage form. J Taibah Univ Sci [Internet]. Taibah University; 2017;11:775\u201381. Available from: https:\/\/doi.org\/10.1016\/j.jtusci.2016.10.004","DOI":"10.1016\/j.jtusci.2016.10.004"},{"key":"3467_CR39","doi-asserted-by":"publisher","unstructured":"Ipar VS, Dsouza A, Devarajan P V. Enhancing curcumin oral bioavailability through nanoformulations. Eur J Drug Metab Pharmacokinet [Internet]. Springer International Publishing; 2019; Available from: https:\/\/doi.org\/10.1007\/s13318-019-00545-z","DOI":"10.1007\/s13318-019-00545-z"},{"key":"3467_CR40","doi-asserted-by":"publisher","unstructured":"Lazar AN, Mourtas S, Youssef I, Parizot C, Dauphin A, Delatour B, et al. Curcumin-conjugated nanoliposomes with high affinity for A \u03b2 deposits\u202f: Possible applications to Alzheimer disease. Nanomedicine Nanotechnology, Biol Med [Internet]. Elsevier Inc.; 2013;9:712\u201321. Available from: https:\/\/doi.org\/10.1016\/j.nano.2012.11.004","DOI":"10.1016\/j.nano.2012.11.004"},{"key":"3467_CR41","doi-asserted-by":"publisher","unstructured":"Mourtas S, Lazar AN, Markoutsa E, Duyckaerts C, Antimisiaris SG. Multifunctional nanoliposomes with curcumin-lipid derivative and brain targeting functionality with potential applications for Alzheimer disease. Eur J Med Chem [Internet]. Elsevier Masson SAS; 2014;80:175\u201383. Available from: https:\/\/doi.org\/10.1016\/j.ejmech.2014.04.050","DOI":"10.1016\/j.ejmech.2014.04.050"},{"key":"3467_CR42","unstructured":"Sood S, Jain K, Gowthamarajan K. Curcumin-donepezil\u2013loaded nanostructured lipid carriers for intranasal delivery in an Alzheimer\u2019s disease model. Alzheimer\u2019s Dement [Internet]. 2013 [cited 2016 Jan 9];9:P299. Available from: http:\/\/www.sciencedirect.com\/science\/article\/pii\/S1552526013012661"},{"key":"3467_CR43","doi-asserted-by":"publisher","unstructured":"Kakkar V, Muppu SK, Chopra K, Kaur IP. Curcumin loaded solid lipid nanoparticles: An efficient formulation approach for cerebral ischemic reperfusion injury in rats. Eur J Pharm Biopharm [Internet]. 2013;85:339\u201345. Available from: https:\/\/doi.org\/10.1016\/j.ejpb.2013.02.005","DOI":"10.1016\/j.ejpb.2013.02.005"},{"key":"3467_CR44","doi-asserted-by":"publisher","unstructured":"Sugasini D, Lokesh BR. Prostaglandins , Leukotrienes and essential fatty acids Curcumin and linseed oil co-delivered in phospholipid nanoemulsions enhances the levels of docosahexaenoic acid in serum and tissue lipids of rats. Prostaglandins Leukot Essent Fat Acids [Internet]. Elsevier Ltd; 2017;119:45\u201352. Available from: https:\/\/doi.org\/10.1016\/j.plefa.2017.03.007","DOI":"10.1016\/j.plefa.2017.03.007"},{"key":"3467_CR45","doi-asserted-by":"publisher","first-page":"15","DOI":"10.3109\/03639045.2010.489560","volume":"37","author":"X Wu","year":"2011","unstructured":"Wu X, Xu J, Huang X, Wen C. Self-microemulsifying drug delivery system improves curcumin dissolution and bioavailability. Drug Dev Ind Pharm. 2011;37:15\u201323.","journal-title":"Drug Dev Ind Pharm"},{"key":"3467_CR46","doi-asserted-by":"crossref","unstructured":"Bergonzi MC, Hamdouch R, Mazzacuva F, Isacchi B, Bilia AR. Optimization, characterization and in\u00a0vitro evaluation of curcumin microemulsions. LWT - Food Sci Technol [Internet]. Elsevier Ltd; 2014;59:148\u201355. Available from: http:\/\/www.sciencedirect.com\/science\/article\/pii\/S0023643814003612","DOI":"10.1016\/j.lwt.2014.06.009"},{"key":"3467_CR47","doi-asserted-by":"crossref","unstructured":"Mathew A, Fukuda T, Nagaoka Y, Hasumura T, Morimoto H, Yoshida Y, et al. Curcumin loaded-PLGA nanoparticles conjugated with Tet-1 peptide for potential use in Alzheimer\u2019s disease. PLoS One. 2012;7.","DOI":"10.1371\/journal.pone.0032616"},{"key":"3467_CR48","doi-asserted-by":"crossref","unstructured":"Yin Y-M, Cui F-D, Mu C-F, Choi M-K, Kim JS, Chung S-J, et al. Docetaxel microemulsion for enhanced oral bioavailability: Preparation and in vitro and in vivo evaluation. J Control Release [Internet]. 2009 [cited 2017 Jul 21];140:86\u201394. Available from: http:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168365909005781","DOI":"10.1016\/j.jconrel.2009.08.015"},{"key":"3467_CR49","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1208\/s12248-012-9337-6","volume":"14","author":"A Dahan","year":"2012","unstructured":"Dahan A, Miller JM. The solubility-permeability interplay and its implications in formulation design and development for poorly soluble drugs. AAPS J. 2012;14:244\u201351.","journal-title":"AAPS J"},{"key":"3467_CR50","doi-asserted-by":"crossref","unstructured":"Mathematical models of drug release. Strateg to modify drug release from pharm syst [Internet]. Elsevier; 2015. p. 63\u201386. Available from: https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/B9780081000922000059","DOI":"10.1016\/B978-0-08-100092-2.00005-9"},{"key":"3467_CR51","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/pharmaceutics11010041","volume":"11","author":"S Maher","year":"2019","unstructured":"Maher S, Brayden DJ, Casettari L, Illum L. Application of permeation enhancers in oral delivery of macromolecules: An update. Pharmaceutics. 2019;11:1\u201323.","journal-title":"Pharmaceutics"},{"key":"3467_CR52","doi-asserted-by":"crossref","unstructured":"Shinde, Rajshree L.; Jindal, Anil B.; Devarajan P V. Microemulsions and nanoemulsions for targeted drug delivery to the brain. Curr Nanosci. 2011;7:119\u201333.","DOI":"10.2174\/157341311794480282"},{"key":"3467_CR53","doi-asserted-by":"crossref","unstructured":"Hoosain FG, Choonara YE, Tomar LK, Kumar P, Tyagi C, Du Toit LC, et al. Bypassing p-glycoprotein drug efflux mechanisms: possible applications in pharmacoresistant schizophrenia therapy. Biomed Res Int. Hindawi Publishing Corporation; 2015;2015.","DOI":"10.1155\/2015\/484963"},{"key":"3467_CR54","first-page":"27","volume":"2013","author":"ML Amin","year":"2013","unstructured":"Amin ML. P-glycoprotein inhibition for optimal drug delivery. Drug Target Insights. 2013;2013:27\u201334.","journal-title":"Drug Target Insights"},{"key":"3467_CR55","doi-asserted-by":"crossref","unstructured":"Alqahtani MS, Kazi M, Alsenaidy MA, Ahmad MZ. Advances in oral drug delivery. Front Pharmacol. 2021;12.","DOI":"10.3389\/fphar.2021.618411"},{"key":"3467_CR56","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1016\/S0169-409X(98)00085-4","volume":"36","author":"AH Schinkel","year":"1999","unstructured":"Schinkel AH. P-Glycoprotein, a gatekeeper in the blood-brain barrier. Adv Drug Deliv Rev. 1999;36:179\u201394.","journal-title":"Adv Drug Deliv Rev"},{"key":"3467_CR57","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1007\/s11307-012-0556-0","volume":"14","author":"DME Van Assema","year":"2012","unstructured":"Van Assema DME, Lubberink M, Boellaard R, Schuit RC, Windhorst AD, Scheltens P, et al. P-glycoprotein function at the blood-brain barrier: Effects of age and gender. Mol Imaging Biol. 2012;14:771\u20136.","journal-title":"Mol Imaging Biol"},{"key":"3467_CR58","doi-asserted-by":"crossref","unstructured":"Upadhyay RK. Drug delivery systems, CNS protection, and the blood brain barrier. Biomed Res Int. Hindawi Publishing Corporation; 2014;2014.","DOI":"10.1155\/2014\/869269"},{"key":"3467_CR59","doi-asserted-by":"crossref","unstructured":"Bellettato CM, Scarpa M. Possible strategies to cross the blood \u2013 brain barrier. Ital J Pediatr. 2018;44.","DOI":"10.1186\/s13052-018-0563-0"},{"key":"3467_CR60","doi-asserted-by":"crossref","unstructured":"Teleanu D, Chircov C, Grumezescu A, Volceanov A, Teleanu R. Blood-brain delivery methods using nanotechnology. Pharmaceutics [Internet]. 2018;10:269. Available from: http:\/\/www.mdpi.com\/1999-4923\/10\/4\/269","DOI":"10.3390\/pharmaceutics10040269"},{"key":"3467_CR61","doi-asserted-by":"crossref","unstructured":"Chatterjee B, Sengupta P, Tekade RK. Pharmacokinetic characterization of drugs and new product development. Biopharm Pharmacokinet Considerations Vol 1 Adv Pharm Prod Dev Res. Academic Press; 2021;195\u2013277.","DOI":"10.1016\/B978-0-12-814425-1.00010-3"},{"key":"3467_CR62","doi-asserted-by":"publisher","first-page":"442","DOI":"10.4103\/0975-7406.84463","volume":"3","author":"H Thakkar","year":"2011","unstructured":"Thakkar H, Nangesh J, Parmar M, Patel D. Formulation and characterization of lipid-based drug delivery system of raloxifene-microemulsion and self-microemulsifying drug delivery system. J Pharm Bioallied Sci. 2011;3:442\u20138.","journal-title":"J Pharm Bioallied Sci"},{"key":"3467_CR63","doi-asserted-by":"crossref","unstructured":"da Silva IF, Freitas-Lima LC, Graceli JB, Rodrigues LC de M. Organotins in neuronal damage, brain function, and behavior: A short review. Front Endocrinol (Lausanne). 2018;8:6\u201311.","DOI":"10.3389\/fendo.2017.00366"},{"key":"3467_CR64","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1007\/s11064-012-0932-9","volume":"38","author":"V Corvino","year":"2013","unstructured":"Corvino V, Marchese E, Michetti F, Geloso MC. Neuroprotective strategies in hippocampal neurodegeneration induced by the neurotoxicant trimethyltin. Neurochem Res. 2013;38:240\u201353.","journal-title":"Neurochem Res"},{"key":"3467_CR65","doi-asserted-by":"publisher","first-page":"2995","DOI":"10.1002\/art.20459","volume":"50","author":"B Wang","year":"2004","unstructured":"Wang B, Ma L, Tao X, Lipsky PE. Triptolide, an active component of the Chinese herbal remedy Tripterygium wilfordii Hook F, inhibits production of nitric oxide by decreasing inducible nitric oxide synthase gene transcription. Arthritis Rheum. 2004;50:2995\u20133003.","journal-title":"Arthritis Rheum"},{"key":"3467_CR66","doi-asserted-by":"publisher","first-page":"123","DOI":"10.5487\/TR.2016.32.2.123","volume":"32","author":"A Nirwane","year":"2016","unstructured":"Nirwane A, Sridhar V, Majumdar A. Neurobehavioural changes and brain oxidative stress induced by acute exposure to GSM900 mobile phone radiations in Zebrafish (Danio rerio). Toxicol Res. 2016;32:123\u201332.","journal-title":"Toxicol Res"},{"key":"3467_CR67","doi-asserted-by":"publisher","first-page":"3925","DOI":"10.1007\/s12035-016-9919-x","volume":"54","author":"ME Nunes","year":"2017","unstructured":"Nunes ME, M\u00fcller TE, Braga MM, Fontana BD, Quadros VA, Marins A, et al. Chronic treatment with paraquat induces brain injury, changes in antioxidant defenses system, and modulates behavioral functions in zebrafish. Mol Neurobiol. 2017;54:3925\u201334.","journal-title":"Mol Neurobiol"},{"key":"3467_CR68","doi-asserted-by":"crossref","unstructured":"De Carvalho TS, Cardoso PB, Santos-Silva M, Lima-Bastos S, Luz WL, Assad N, et al. Oxidative Stress Mediates Anxiety-Like Behavior Induced by High Caffeine Intake in Zebrafish: Protective Effect of Alpha-Tocopherol. Oxid Med Cell Longev. 2019;2019.","DOI":"10.1155\/2019\/8419810"}],"container-title":["Pharmaceutical Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11095-022-03467-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11095-022-03467-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11095-022-03467-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,3,23]],"date-time":"2023-03-23T16:10:25Z","timestamp":1679587825000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11095-022-03467-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1,26]]},"references-count":68,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2023,3]]}},"alternative-id":["3467"],"URL":"https:\/\/doi.org\/10.1007\/s11095-022-03467-9","relation":{},"ISSN":["0724-8741","1573-904X"],"issn-type":[{"value":"0724-8741","type":"print"},{"value":"1573-904X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,1,26]]},"assertion":[{"value":"8 September 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 December 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 January 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}}]}}